Pablo Valenzuela | |
|---|---|
 | |
| Born | June 13, 1941[1] |
| Nationality | Chilean |
| Alma mater | University of Chile, Northwestern University |
| Known for | Molecular genetic studies of HBV, HCV, HIV and the invention of the first recombinant vaccine, against HBV. Directed scientists which discovered HCV at Chiron Corporation. |
| Awards | Chilean National Prize for Applied Sciences and Technologies (2002) |
| Scientific career | |
| Fields | Biotechnology |
| Institutions | Fundacion Ciencia Para la Vida Pontifical Catholic University of Chile Universidad Nacional Andres Bello Universidad San Sebastian |
Pablo Valenzuela (Latin American Spanish: [ˈpaβlo βalenˈswela]; born June 13, 1941) is a Chilean biochemist dedicated to biotechnology development.[2] He is known for his genetic studies of hepatitis viruses; participated as R&D Director in the discovery of hepatitis C virus and the invention of the world's first recombinant vaccine (against hepatitis B virus). He is one of the cofounders of the biotechnology company Chiron Corporation and of Fundacion Ciencia para la Vida,[3] a private non profit institution where he is currently working.
- ^ "Pablo Valenzuela". Retrieved 19 January 2013.
- ^ This is Chile Archived 2011-07-25 at the Wayback Machine
- ^ "Fundacion Ciencia Para la Vida". Archived from the original on 2011-02-08. Retrieved 2011-01-10.